ONTOLOGY REPORT - ANNOTATIONS
| Term: | (R)-adrenaline |
|
| Accession: | CHEBI:28918
|
browse the term
|
| Definition: | The R-enantiomer of adrenaline. |
| Synonyms: | exact_synonym: | 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol |
| | related_synonym: | (-)-(R)-epinephrine; (-)-3,4-dihydroxy-alpha-((methylamino)methyl)benzyl alcohol; (R)-(-)-Adnephrine; (R)-(-)-Epirenamine; 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol; Adrenalin; C9H13NO3; CNC[C@H](O)c1ccc(O)c(O)c1; Epinephrin; Epipen; Epipen JR; InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1; InChIKey=UCTWMZQNUQWSLP-VIFPVBQESA-N; L-Adrenaline; Primatene; adrenaline; epinefrina; epinephrine; epinephrinum; levoepinephrine |
| | alt_id: | CHEBI:1942; CHEBI:23928 |
| | xref_casrn: | 51-43-4 |
| | xref: | Beilstein:2368277 "Beilstein Registry Number"; ChEMBL:128976 "ChEMBL COMPOUND"; ChemIDplus:51-43-4 "CAS Registry Number"; CiteXplore:18325983 "PubMed citation"; CiteXplore:21963816 "PubMed citation"; CiteXplore:22115931 "PubMed citation"; CiteXplore:22405854 "PubMed citation"; CiteXplore:22425731 "PubMed citation"; CiteXplore:22429969 "PubMed citation"; CiteXplore:22569014 "PubMed citation"; CiteXplore:22623754 "PubMed citation"; CiteXplore:22826982 "PubMed citation"; CiteXplore:22895980 "PubMed citation"; CiteXplore:22898765 "PubMed citation"; CiteXplore:22905594 "PubMed citation"; CiteXplore:22940899 "PubMed citation"; CiteXplore:23066296 "PubMed citation"; CiteXplore:23130169 "PubMed citation"; CiteXplore:23164182 "PubMed citation"; CiteXplore:23185846 "PubMed citation"; DrugBank:DB00668 "DrugBank"; HMDB:HMDB00068 "HMDB"; KEGG COMPOUND:51-43-4 "CAS Registry Number"; KEGG COMPOUND:C00788 "KEGG COMPOUND"; KEGG DRUG:D00095 "KEGG DRUG" |
| | xref_mesh: | MESH:D004837 |
| | xref: | MetaCyc:L-EPINEPHRINE "MetaCyc"; NIST Chemistry WebBook:51-43-4 "CAS Registry Number"; Reaxys:2368277 "Reaxys Registry Number"; Wikipedia:Epinephrine "Wikipedia" |
| | cyclic_relationship: | is_conjugate_base_of CHEBI:71406; is_enantiomer_of CHEBI:40751 |
|
|
(R)-adrenaline
|
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases export |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abp1 |
amiloride binding protein 1 (amine oxidase, copper-containing) |
|
multiple interactions |
EXP |
4 |
76,957,477 |
76,977,643 |
RGD:6480464 |
CTD |
| G |
Abp1 |
amiloride binding protein 1 (amine oxidase, copper-containing) |
|
increases activity |
EXP |
4 |
76,957,477 |
76,977,643 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
increases expression |
EXP |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Actn1 |
actinin, alpha 1 |
|
increases expression |
EXP |
6 |
103,188,593 |
103,282,873 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
multiple interactions |
EXP |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
affects binding |
ISO |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
multiple interactions |
ISO |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
increases activity |
ISO |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
multiple interactions |
ISO |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
multiple interactions |
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
increases activity |
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
multiple interactions |
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
affects binding |
ISO |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
multiple interactions |
ISO |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
increases activity |
ISO |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
multiple interactions |
ISO |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adra2b |
adrenoceptor alpha 2B |
|
multiple interactions |
ISO |
3 |
114,867,357 |
114,869,680 |
RGD:6480464 |
CTD |
| G |
Adra2c |
adrenoceptor alpha 2C |
|
multiple interactions |
ISO |
14 |
81,107,907 |
81,109,610 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
multiple interactions |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
multiple interactions |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
multiple interactions |
EXP |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
multiple interactions |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
increases activity |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
increases activity |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
affects response to substance |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
multiple interactions |
ISO |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
multiple interactions |
EXP |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
multiple interactions |
ISO |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
multiple interactions |
ISO |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
multiple interactions |
ISO |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Adrbk1 |
adrenergic, beta, receptor kinase 1 |
|
multiple interactions |
ISO |
1 |
206,873,002 |
206,892,868 |
RGD:6480464 |
CTD |
| G |
Ak2 |
adenylate kinase 2 |
|
decreases expression |
EXP |
5 |
148,156,751 |
148,176,195 |
RGD:6480464 |
CTD |
| G |
Ak2 |
adenylate kinase 2 |
|
multiple interactions |
EXP |
5 |
148,156,751 |
148,176,195 |
RGD:6480464 |
CTD |
| G |
Aqp7 |
aquaporin 7 |
|
affects localization |
ISO |
5 |
58,433,731 |
58,447,853 |
RGD:6480464 |
CTD |
| G |
Aqp7 |
aquaporin 7 |
|
increases expression |
ISO |
5 |
58,433,731 |
58,447,853 |
RGD:6480464 |
CTD |
| G |
Aqp7 |
aquaporin 7 |
|
multiple interactions |
ISO |
5 |
58,433,731 |
58,447,853 |
RGD:6480464 |
CTD |
| G |
Atp5a1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
|
increases expression |
EXP |
18 |
74,735,267 |
74,743,088 |
RGD:6480464 |
CTD |
| G |
C1qbp |
complement component 1, q subcomponent binding protein |
|
multiple interactions |
EXP |
10 |
57,881,783 |
57,886,434 |
RGD:6480464 |
CTD |
| G |
C1qbp |
complement component 1, q subcomponent binding protein |
|
increases expression |
EXP |
10 |
57,881,783 |
57,886,434 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
increases expression |
ISO |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases abundance |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
multiple interactions |
ISO |
1 |
117,587,580 |
117,716,267 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
increases methylation |
ISO |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
multiple interactions |
ISO |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
increases methylation |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
multiple interactions |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
multiple interactions |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
multiple interactions |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
multiple interactions |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
increases abundance |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Csk |
c-src tyrosine kinase |
|
multiple interactions |
ISO |
8 |
61,381,336 |
61,386,013 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
increases expression |
ISO |
2 |
190,394,854 |
190,405,668 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
increases expression |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Dbh |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
affects abundance |
ISO |
3 |
6,052,706 |
6,069,826 |
RGD:6480464 |
CTD |
| G |
Des |
desmin |
|
multiple interactions |
EXP |
9 |
74,637,783 |
74,645,499 |
RGD:6480464 |
CTD |
| G |
Des |
desmin |
|
decreases expression |
EXP |
9 |
74,637,783 |
74,645,499 |
RGD:6480464 |
CTD |
| G |
Dlat |
dihydrolipoamide S-acetyltransferase |
|
multiple interactions |
EXP |
8 |
53,989,491 |
54,014,779 |
RGD:6480464 |
CTD |
| G |
Echs1 |
enoyl CoA hydratase, short chain, 1, mitochondrial |
|
multiple interactions |
EXP |
1 |
199,901,585 |
199,910,412 |
RGD:6480464 |
CTD |
| G |
Etfb |
electron-transfer-flavoprotein, beta polypeptide |
|
multiple interactions |
EXP |
1 |
93,820,124 |
93,834,288 |
RGD:6480464 |
CTD |
| G |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
|
affects expression |
EXP |
5 |
149,340,525 |
149,347,268 |
RGD:6480464 |
CTD |
| G |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
|
multiple interactions |
EXP |
5 |
149,340,525 |
149,347,268 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
multiple interactions |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fh |
fumarate hydratase |
|
increases expression |
EXP |
13 |
91,329,837 |
91,355,722 |
RGD:6480464 |
CTD |
| G |
Grk5 |
G protein-coupled receptor kinase 5 |
|
multiple interactions |
ISO |
1 |
267,495,534 |
267,693,144 |
RGD:6480464 |
CTD |
| G |
Hadh |
hydroxyacyl-CoA dehydrogenase |
|
multiple interactions |
EXP |
2 |
228,698,545 |
228,751,691 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
multiple interactions |
EXP |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
affects localization |
EXP |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
|
multiple interactions |
EXP |
9 |
11,033,496 |
11,038,868 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
increases expression |
EXP |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
multiple interactions |
EXP |
18 |
27,419,614 |
27,437,031 |
RGD:6480464 |
CTD |
| G |
Hspb6 |
heat shock protein, alpha-crystallin-related, B6 |
|
decreases expression |
EXP |
1 |
85,599,075 |
85,601,214 |
RGD:6480464 |
CTD |
| G |
Hspb6 |
heat shock protein, alpha-crystallin-related, B6 |
|
multiple interactions |
EXP |
1 |
85,599,075 |
85,601,214 |
RGD:6480464 |
CTD |
| G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
decreases expression |
EXP |
1 |
135,876,052 |
135,895,373 |
RGD:6480464 |
CTD |
| G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
multiple interactions |
EXP |
1 |
135,876,052 |
135,895,373 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
decreases expression |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
decreases expression |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Itga2 |
integrin, alpha 2 |
|
multiple interactions |
ISO |
2 |
46,967,681 |
47,080,909 |
RGD:6480464 |
CTD |
| G |
Itgav |
integrin, alpha V |
|
increases expression |
ISO |
3 |
66,953,403 |
67,029,774 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
increases response to substance |
EXP |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
multiple interactions |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
increases activity |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
affects localization |
EXP |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
increases expression |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
affects activity |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases activity |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
affects activity |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases activity |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Myl2 |
myosin, light chain 2, regulatory, cardiac, slow |
|
multiple interactions |
EXP |
12 |
35,653,745 |
35,664,700 |
RGD:6480464 |
CTD |
| G |
Myl2 |
myosin, light chain 2, regulatory, cardiac, slow |
|
affects expression |
EXP |
12 |
35,653,745 |
35,664,700 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
increases expression |
EXP |
4 |
162,435,781 |
162,506,961 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
decreases activity |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2ry12 |
purinergic receptor P2Y, G-protein coupled, 12 |
|
multiple interactions |
ISO |
2 |
148,611,035 |
148,613,985 |
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Phgdh |
phosphoglycerate dehydrogenase |
|
increases expression |
EXP |
2 |
193,147,943 |
193,177,137 |
RGD:6480464 |
CTD |
| G |
Pkm |
pyruvate kinase, muscle |
|
multiple interactions |
EXP |
8 |
63,486,492 |
63,508,016 |
RGD:6480464 |
CTD |
| G |
Ppp2r1a |
protein phosphatase 2, regulatory subunit A, alpha |
|
decreases expression |
EXP |
1 |
58,442,220 |
58,461,462 |
RGD:6480464 |
CTD |
| G |
Ppp2r1a |
protein phosphatase 2, regulatory subunit A, alpha |
|
multiple interactions |
EXP |
1 |
58,442,220 |
58,461,462 |
RGD:6480464 |
CTD |
| G |
Prdx6 |
peroxiredoxin 6 |
|
multiple interactions |
EXP |
13 |
76,824,968 |
76,835,517 |
RGD:6480464 |
CTD |
| G |
Prdx6 |
peroxiredoxin 6 |
|
decreases expression |
EXP |
13 |
76,824,968 |
76,835,517 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
affects response to substance |
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Prkce |
protein kinase C, epsilon |
|
affects response to substance |
EXP |
6 |
9,631,234 |
10,097,311 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases activity |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
multiple interactions |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases activity |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Sct |
secretin |
|
multiple interactions |
EXP |
1 |
201,472,250 |
201,472,944 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
EXP |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases activity |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases activity |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Suclg2 |
succinate-CoA ligase, GDP-forming, beta subunit |
|
increases expression |
EXP |
4 |
129,995,856 |
130,276,182 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
increases chemical synthesis |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Thy1 |
Thy-1 cell surface antigen |
|
multiple interactions |
ISO |
8 |
47,027,721 |
47,031,857 |
RGD:6480464 |
CTD |
| G |
Thy1 |
Thy-1 cell surface antigen |
|
decreases expression |
ISO |
8 |
47,027,721 |
47,031,857 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases secretion |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
increases expression |
EXP |
10 |
37,795,721 |
37,823,253 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
multiple interactions |
EXP |
10 |
37,795,721 |
37,823,253 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
multiple interactions |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
multiple interactions |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
Term paths to the root
|